Evidence map›Paper›PMID 32128998›Full record

ArticleJournal of the International AIDS Society2020

Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.

Aneth V Kalinjuma, Tracy R Glass, Maja Weisser, Selarine J Myeya, Bryson Kasuga, Yassin Kisung'a, George Sikalengo, Andrew Katende, Manuel Battegay, Fiona Vanobberghen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Aneth V KalinjumaIfakara Health Institute, Ifakara, Tanzania.ORCID 0000-0001-5862-9264
Tracy R GlassSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID 0000-0001-7075-9803
Maja WeisserIfakara Health Institute, Ifakara, Tanzania.
Selarine J MyeyaIfakara Health Institute, Ifakara, Tanzania.
Bryson KasugaUSAID Boresha Afya, Morogoro, Tanzania.
Yassin Kisung'aIfakara Health Institute, Ifakara, Tanzania.
George SikalengoIfakara Health Institute, Ifakara, Tanzania.
Andrew KatendeIfakara Health Institute, Ifakara, Tanzania.
Manuel BattegayUniversity of Basel, Basel, Switzerland.
Fiona VanobberghenSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID 0000-0002-8908-0953
KIULARCO Study Group
Ifakara Health Institute · TZSwiss Tropical and Public Health Institute · CHUniversity of Basel · CH

Funding

PEPFAR
6 · The paper itself

Abstract

introductionLifelong antiretroviral therapy (ART) improves health outcomes for HIV-positive individuals, but is jeopardized by irregular clinic attendance and hence poor adherence. Loss to follow-up (LTFU) is typically defined retrospectively but this may lead to biased inferences. We assessed incidence of and factors associated with LTFU, prospectively and accounting for recurrent LTFU episodes, in the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) of HIV-positive persons in rural Tanzania.

methodsWe included adults (≥15 years) enrolled in 2005 to 2016, regardless of ART status, with follow-up through April 2017. LTFU was defined as >60 days late for a scheduled appointment. Participants could experience multiple LTFU episodes. We performed analyses based on the first (prospective) and last (retrospective) events observed during follow-up, and accounting for recurrent LTFU episodes. Time to LTFU was estimated using cumulative incidence functions. We assessed factors associated with LTFU using cause-specific proportional hazards, marginal means/rates, and Prentice, Williams and Peterson models.

resultsAmong 8087 participants (65% female, 60% aged ≥35 years, 42% WHO stage 3/4, and 47% CD4 count <200 cells/mm

conclusionsLTFU episodes were common and prompt tracing efforts are urgently needed. We identified socio-demographic and clinical characteristics associated with LTFU that can be used to target tracing efforts and to help inform the design of appropriate interventions. Incidence of and risk factors for LTFU differed based on the LTFU definition applied, highlighting the importance of appropriately accounting for recurrent LTFU episodes. We recommend using a prospective definition of LTFU combined with recurrent event analyses in cohorts where repeated interruptions in care are common.

Indexed as

Lost to Follow-UpAdolescentAdultAnti-HIV AgentsCD4 Lymphocyte CountCohort StudiesFemaleHIV InfectionsHIV SeropositivityHumansIncidenceMaleMiddle AgedPregnancyProspective StudiesRetrospective StudiesAnti-HIV AgentscohortHIV infectionslost to follow-upproportional hazards modelsrecurrent eventsTanzania

Identifiers

PMID32128998
PMCPMC7054631
OpenAlexW3010566395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.